| Trial ID: | L3372 |
| Source ID: | NCT00563225
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
20 Week Bridging Study in Type II DM
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type II
|
| Interventions: |
DRUG: Insulin Glargine
|
| Outcome Measures: |
Primary: To evaluate safety & efficacy of Insulin glargine ( injection at bedtime, once a day) on the changes of HbA1c. | Secondary: To evaluate the efficacy of Insulin glargine (injection at bedtime, once a day) on the changes of FPG.
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-10
|
| Completion Date: |
2004-04
|
| Results First Posted: |
|
| Last Update Posted: |
2007-11-26
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00563225
|
